Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kateřina Burčková"'
Autor:
Karla Plevova, Hana Skuhrova Francova, Katerina Burckova, Yvona Brychtova, Michael Doubek, Sarka Pavlova, Jitka Malcikova, Jiri Mayer, Boris Tichy, Sarka Pospisilova
Publikováno v:
Haematologica, Vol 99, Iss 2 (2014)
In chronic lymphocytic leukemia, usually a monoclonal disease, multiple productive immunoglobulin heavy chain gene rearrangements are identified sporadically. Prognostication of such cases based on immunoglobulin heavy variable gene mutational status
Externí odkaz:
https://doaj.org/article/7ba0ddcbf2c14e9e8ac6122a2aac68fa
Autor:
A Vítek, Kyra Michalova, Petr Soukup, Jacqueline Maaloufová, Alena Dohnalova, Petr Cetkovský, Jana Březinová, Jiří Schwarz, Jana Markova, Kateřina Burčková, Petra Michková
Publikováno v:
European Journal of Haematology. 88:128-135
Objectives: Recently, mutations in DNMT3A gene have been described in about 25% acute myeloid leukemia (AML) cases, preferentially in monocytic AML. They were found to predict worse overall survival (OS) of mutated patients. Patients and methods: RT-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0305e0fb4ebd26e282aecfb4a955439a
https://doi.org/10.1111/j.1600-0609.2011.01716.x
https://doi.org/10.1111/j.1600-0609.2011.01716.x
Autor:
Jana, Marková, Petra, Michková, Kateřina, Burčková, Jana, Březinová, Kyra, Michalová, Alena, Dohnalová, Jacqueline Soukupová, Maaloufová, Petr, Soukup, Antonín, Vítek, Petr, Cetkovský, Jiří, Schwarz
Publikováno v:
European journal of haematology. 88(2)
Recently, mutations in DNMT3A gene have been described in about 25% acute myeloid leukemia (AML) cases, preferentially in monocytic AML. They were found to predict worse overall survival (OS) of mutated patients.RT-PCR followed by direct sequencing w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aba3f3f16edc697d6995c20f403af02a
https://pubmed.ncbi.nlm.nih.gov/21967546
https://pubmed.ncbi.nlm.nih.gov/21967546
Autor:
Šárka Pospíšilová, Anna Panovská, Kateřina Burčková, Tomáš Loja, Michael Doubek, Olga Stehlíková, Yvona Brychtová, H. Francová Skuhrová, Jana Chovancová, Jiří Mayer, Marta Krejčí, B. Tichý, Marek Borský
Publikováno v:
International Journal of Laboratory Hematology
International Journal of Laboratory Hematology; Vol 36
International Journal of Laboratory Hematology; Vol 36
Introduction Minimal residual disease (MRD) detection has become increasingly important for the assessment of therapy response in chronic lymphocytic leukemia (CLL). However, current MRD analysis methods, both molecular genetic and flow cytometric, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a048e93ecccc491492e998afbd50f94